Flu News and Research

RSS

The effect of weather on COVID-19 infection rate

Viral epidemics are nothing new in human history. Several viruses circulate freely every year among human beings, causing seasonal outbreaks of disease and death, such as the seasonal flu. A new study published on the preprint server medRxiv* reports that temperature plays a significant role in the growth of the ongoing COVID-19 pandemic.

6 May 2020

Antibiotic Resistance: The Patient Perspective

We discuss the impact of antibiotic-resistant infections on everyday life and the work that is being done to overcome this issue with Antibiotic Research UK.

From Bionow 6 May 2020

Public perception of SARS-CoV-2 influences health behavior

A new study published in the Journal of Risk Research in April 2020 shows that public health behaviors aimed at preventing viral spread are influenced by public risk perception, which varies between countries around the world.

6 May 2020

First French COVID-19 case was in December 19

The coronavirus disease (COVID-19), formerly known as the novel coronavirus infection, was first reported in late December 2019 in Wuhan City in China. Many health experts believe that the virus had spread way before it was identified as the culprit for many pneumonia-like diseases. Now, a French doctor says that the coronavirus reached France back in December when it admitted a pneumonia patient into hospital.

5 May 2020

Indian physicians’ petition puts focus on race risks in the wake of COVID-19

A group of leading, ethnic Indian physicians has petitioned Britain's National Health Service (NHS) to formally include ethnicity as a COVID-19 infection risk factor for healthcare workers in the UK.

5 May 2020

Study: Brazilian president’s attitude to coronavirus increases 'risky behavior' in the country

Jair Bolsonaro's public undermining of pandemic prevention efforts reduces social distancing in the parts of Brazil where his voter base is strongest, according to a new study using location data from over 60 million phones.

4 May 2020

ASU team identifies new, unique SARS-CoV-2 mutation

As the coronavirus pandemic has swept across the U.S., in addition to tracking the number of COVID daily cases, there is a worldwide scientific community engaged in tracking the SARS-CoV-2 virus itself.

4 May 2020

New initiative to speed up development and commercialization of COVID-19 testing technologies

UMass Medical School and UMass Lowell will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies via their Center for Advancing Point of Care Technologies collaboration.

4 May 2020

Researchers examine role of immune response in COVID-19 patients

A new USC study suggests that temporarily suppressing the body's immune system during the early stages of COVID-19 could help a patient avoid severe symptoms.

4 May 2020

Using Multiplex Assays to Discover Biomarkers for Parkinson’s Disease

In this interview, Dr. Polinski and Dr. Atabakhsh discuss the importance of developing biomarkers for Parkinson’s and the partnership between MJFF and Abcam.

From Abcam 1 May 2020

Spike protein analysis from India's first SARS-CoV-2

A new study published on the preprint server bioRxiv analyzes viral spike protein sequences from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in West Bengal, India, comparing them with sequences from other Indian states and Wuhan, China.

30 Apr 2020

NIH announces new initiative to speed up COVID-19 testing technologies

The National Institutes of Health today announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic.

30 Apr 2020

Study: 14.4 million U.S. workers face exposure to infection on the job

A University of Washington researcher calculates that 14.4 million workers face exposure to infection once a week and 26.7 million at least once a month in the workplace, pointing to an important population needing protection as the novel coronavirus disease, COVID-19, continues to break out across the U.S.

29 Apr 2020

Radboudumc researchers find essential mechanism in the disease process of COVID-19

Researchers at the Radboud University Medical Center seem to have found an essential mechanism in the disease process of COVID-19, which has so far been overlooked.

29 Apr 2020

COVID tests are free, except when they’re not

Even before a novel virus swept around the world, Anna Davis Abel wore a mask to protect herself from getting sick.

29 Apr 2020

India to deploy homegrown tech against COVID-19

When India's 1.3 billion people come out of a 40-day lockdown on 3 May, imposed to contain the spread of COVID-19, they can hope that a battery of technologies that the government is readying to deploy against the contagious virus could offer them some protection.

28 Apr 2020

Researchers develop new method for remotely stimulating activity in deep brain regions

University of Texas at Dallas researchers have developed a promising method for remotely stimulating activity in deep brain regions, advancing understanding of how molecules act in the brain and paving the way for better cancer treatments and therapies for other diseases.

27 Apr 2020

Misinformation on COVID-19 is tied to media usage

People who relied on conservative media or social media in the early days of the COVID-19 outbreak were more likely to be misinformed about how to prevent the virus and believe conspiracy theories about it, a study of media use and public knowledge has found.

25 Apr 2020

Study looks into COVID‐19 preparedness in Michigan nursing homes

The COVID-19 pandemic has hit some nursing homes especially hard - including in the hotspot state of Michigan. Hundreds of deaths of residents in homes from Seattle to Boston have raised concerns about how well facilities are protecting the 1.3 million older Americans who live in them.

24 Apr 2020

Biosero and Scripps Research Institute offer automated lab screening for COVID-19 drug therapy candidates

Biosero has designed and implemented an automated lab workflow for Scripps Research Institute so researchers can accelerate the screening of COVID-19 drug therapy candidates.

24 Apr 2020